EPCAM and Familial prostate cancer: CellSearch uses magnetically tagged antibodies in order to enrich the samples before staining with antibodies which target cell surface markers such as epithelial cell adhesion molecule (EpCAM) to identify malignant cells, and to date, is the only FDA approved method to detect CCs in breast, colorectal and prostate cancer.